Phospho-Rb (Ser807/811) Antibody

About the Target

The retinoblastoma (RB) tumor suppressor regulates cell cycle progression by interacting with E2F transcription factors. Binding of RB to E2F at gene promoters crucial for S phase progression inhibits transcription by preventing co-activator recruitment or promoting co-repressor recruitment. Mitogen-induced activation of cyclin-dependent kinases (CDK4, CDK6, and CDK2) phosphorylates RB, relieving its inhibition on cell cycle transition from G1 to S phase. Depending on the literature source, RB may also be discussed as Phospho-Rb (Ser807/811).

Reported cellular context includes cytoplasm and nucleus, which can matter when signal is compared across treatments or changing cell states. Following RB across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

RB is commonly interpreted in the context of cancer and cell cycle research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cytoplasm and nucleus across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• cell-cycle linked differences in abundance, timing, or compartmental enrichment
• differences between total target abundance and site-specific regulation when modified forms are compared

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for RB. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in RB reflect biology rather than handling. When interpreting RB, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep RB trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.